Refractory Visual Pathway Glioma
specificVisual pathway glioma that is resistant to treatment.
8
Centers
4
Active Trials
—
Cancer Funding
Top Centers for Refractory Visual Pathway Glioma(8)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 67.5 |
| 2 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 67.5 |
| 3 | University of Illinois Cancer CenterChicago, IL Active Research Program | 67.5 |
| 4 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 67.5 |
| 5 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 45.0 |
| 6 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive | 45.0 |
| 7 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive | 45.0 |
| 8 | Boston University Cancer CenterBoston, MA | 45.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →